3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
55
Breast Neoplasms
29
Neoplasms
25
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Colonic Neoplasms
6
Polycystic Ovary Syndrome
5
Pancreatic Neoplasms
5
Obesity
5
Lymphoma
5
Fatigue
5
Multiple Myeloma
4
Lymphoma, Follicular
4
Lymphedema
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Stomach Neoplasms
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia
3
Hematologic Neoplasms
3
Skin Neoplasms
2
Sarcopenia
2
Recurrence
2
Rectal Neoplasms
2
Peripheral Nervous System Diseases
2
Neoplasm Metastasis
2
Melanoma
2
Interventions
Gemcitabine
32
Cisplatin
31
durvalumab
15
pembrolizumab
14
Fluorouracil
13
Oxaliplatin
12
Leucovorin
12
Capecitabine
10
Bevacizumab
8
lenvatinib
7
Nivolumab
7
zanidatamab
4
Trastuzumab
4
S 1 (combination)
4
Paclitaxel
4
Liquid Biopsy
4
Irinotecan
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
tremelimumab
3
tislelizumab
3
irinotecan sucrosofate
3
Injections
3
Folfox protocol
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
pertuzumab
2
niraparib
2
ivosidenib
2
envafolimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Exercise
×
1 year
×
Clear all
NCT05044065
2025-08-27
PREV-Ex
Karolinska Institutet
Phase NA
Completed
52 enrolled